Latest

07:21
[ Antengene Corporation Limited (06996.HK): Expected to Swing to Profit in Interim Period, Revenue to Hit RMB 490 Million to RMB 536 Million ] NewTimeSpace News: Antengene Corporation Limited announced on July 28 that the Group expects its revenue for the first half of 2026 to range from RMB 490 million to RMB 536 million, with profits projected at RMB 195 million to RMB 238 million.
Tag： Antengene Corporation Limited06996.HK
21:56
[ FOREST CABIN(02657.HK) will spend HKD 28.4 million to repurchase 543 thousand shares on Jul 27, 2026 ] FOREST CABIN(02657.HK) will spend HKD 28.4 million to repurchase 543 thousand shares on Jul 27, 2026 .
Tag： FOREST CABIN02657.HK
21:52
[ CSPC Pharmaceutical (01093.HK): NDA for Sirolimus Albumin-Bound Injection Accepted by NMPA with Breakthrough Therapy and Priority Review Status ] NewTimeSpace News: CSPC Pharmaceutical announced that its self-developed Sirolimus for Injection (Albumin-Bound) has been accepted by the NMPA and granted both Breakthrough Therapy designation and priority review status for the proposed indication of unresectable locally advanced or metastatic malignant PEComa, with pivotal Phase III data meeting the primary endpoint and demonstrating significant efficacy, positioning it as the first intravenous sirolimus formulation in China for this rare and refractory tumor type.
Tag： CSPC PHARMA01093.HK
21:49
[ Guotai Haitong (02611.HK): Signs Formal Agreement with Orient Securities to Sell 24.99% Stake in Shanghai Securities for RMB 25.12 Billion ] NewTimeSpace News: Guotai Haitong signed a formal agreement on 27 July 2026 to sell its 24.99% stake in Shanghai Securities to Orient Securities as part of a RMB 25.12 billion deal for 100% of Shanghai Securities, under which Guotai Haitong will receive 457.48 million Orient Securities A-shares and RMB 1.57 billion in cash, exiting its direct holding while expecting to book a gain of about RMB 29.7 million.
Tag： Guotai Haitong02611.HK
21:47
[ Broncus Holding (02216.HK): BroncTru® Catheter Secures EU MDR CE Certification, Strengthening Global Product Layout ] NewTimeSpace News: Broncus Holding announced that its BroncTru® disposable bronchoscopic dilation catheter has obtained EU MDR CE certification, marking significant progress in the company's international registration and global product deployment. The product has already secured approvals from NMPA, FDA, and EU CE, and is cleared for sale in Taiwan, Indonesia, Thailand, and Malaysia.
Tag： BRONCUS-B02216.HK
20:02
[ MINIMAX-W(00100.HK) closed 17.14% higher, the Hang Seng Software & Services Sector saw divergent trends ] By the close of trading on Jul 27, 2026, MINIMAX-W(00100.HK) saw a gain of 17.14% in its share price, closing at HKD 229.6. During the session, it reached an intraday high of HKD 231.8 and touched an intraday low of HKD 186.2.
Tag： MINIMAX-W00100.HK
20:02
[ HAIER SMARTHOME(06690.HK) will spend CNY 45.98 million to repurchase 2.1 million shares on Jul 27, 2026 ] HAIER SMARTHOME(06690.HK) will spend CNY 45.98 million to repurchase 2.1 million shares on Jul 27, 2026 .
Tag： HAIER SMARTHOME06690.HK
20:02
[ TH MEDICAL-B(02697.HK) closed 9.85% higher, the Hang Seng Healthcare Equipment & Services Sector saw divergent trends ] By the close of trading on Jul 27, 2026, TH MEDICAL-B(02697.HK) saw a gain of 9.85% in its share price, closing at HKD 602. During the session, it reached an intraday high of HKD 620 and touched an intraday low of HKD 543.5.
Tag： TH MEDICAL-B02697.HK
17:54
[ ASIA FINANCIAL (00662.HK): Liao Haoxuan Appointed Chief Financial Officer with Effect from 27 July ] NewTimeSpace News: Asia Financial Holdings Limited (00662.HK) announced on 27 July the appointment of Liao Haoxuan as Chief Financial Officer, effective immediately. Mr. Liao is a certified accountant in Hong Kong and the United Kingdom, with financial experience at investment management firms and global professional services firms.
Tag： ASIA FINANCIAL00662.HKSenior Management
17:48
[ INNOCARE (09969.HK): Phase III Trial of Fadeucravacitinib (ICP-488) for Moderate to Severe Plaque Psoriasis Meets Primary Endpoint ] NewTimeSpace News: InnoCare Pharma Limited (09969.HK) announced that the pivotal Phase III registration trial of fadeucravacitinib (ICP-488), a potent and highly selective TYK2 allosteric inhibitor, for patients with moderate to severe plaque psoriasis has successfully met the statistically significant primary endpoint and delivered clinically meaningful improvements. The safety profile is consistent with previous studies with no new safety signals identified.
Tag： INNOCARE09969.HKClinical Trialprimary endpoint
17:36
[ ZHONGJI INNOLIGHT (03308.HK): Public Offer Closes Today, Margin Subscription Hits HK$71.99014 Billion ] NewTimeSpace News: The public offer of Zhongji Innolight (03308.HK) closes today (27 July). As of 14:00, margin subscription amounted to approximately HK$71.99 billion. The public offer fundraising target stands at HK$5.505 billion, representing an over-subscription rate of roughly 12.08 times. The maximum offer price is HK$1,010 per share, with each board lot comprising 50 shares and an entry cost of about HK$51,009.29. Listing is scheduled for 30 July.
Tag： Zhongji Innolight03308.HKmargin subscriptionIPO
17:32
[ Extreme Vision (06636.HK): Interim Revenue Forecast to Surge 160%–180%, Turnaround in Adjusted Net Profit ] NewTimeSpace News: Extreme Vision disclosed in an announcement dated 27 July that the Group expects its revenue for the first half of 2026 to reach approximately RMB 153 million to RMB 165 million, representing a year-on-year increase of 160% to 180%. The maximum non-IFRS adjusted net profit is projected at around RMB 6 million.
Tag： EXTREME VISION06636.HK
17:23
[ China Glass Holdings(03300.HK): Expected to Swing to Profit in Interim Period, Net Profit Forecasted at RMB 35 Million to RMB 65 Million ] NewTimeSpace News: China Glass Holdings disclosed in an announcement dated 27 July that the Group expects to record a net profit of approximately RMB 35 million to RMB 65 million for the six months ended 30 June 2026, swinging from a loss of around RMB 318.7 million in the corresponding period last year.
Tag： China Glass Holdings03300.HK
17:18
[ Anhui Expressway(00995.HK): Plans to Issue Corporate Bonds of Up to RMB 800 Million ] NewTimeSpace News: Anhui Expressway disclosed in an announcement dated 27 July that, pursuant to the approval granted by the China Securities Regulatory Commission (CSRC), the Board of Directors intends to publicly offer Phase I 2026 corporate bonds to professional investors in mainland China with an aggregate principal amount not exceeding RMB 800 million. Tranche 1 carries a 3-year tenor, and Tranche 2 has a 5-year tenor.
Tag： Anhui Expressway00995.HK
17:13
[ HBM Holdings(02142.HK): Strategic Cooperation Established with Sinopharm Group ] NewTimeSpace News: HBM Holdings announced on July 27 that the Company has signed a strategic cooperation agreement with Sinopharm Group.
Tag： HBM Holdings02142.HK
17:11
[ CITIC SEC (06030.HK): Controlled Subsidiary ChinaAMC Posts H1 Revenue of RMB5.708 Billion and Net Profit of RMB1.413 Billion ] NewTimeSpace News: On 27 July, CITIC SEC(06030.HK) announced that its controlled subsidiary China Asset Management Co., Ltd. recorded revenue of RMB5.708 billion and net profit of RMB1.413 billion in the first half of 2026, with AUM reaching RMB2.91 trillion. The figures are unaudited.
Tag： CITIC SEC06030.HKChina AMC
17:10
[ Transport International(00062.HK): Change of Company Secretary and Authorised Representative ] NewTimeSpace News: Transport Internationa announced in a filing dated 27 July that Mr. Yu Huizhang will retire from his posts as Company Secretary and Authorised Representative, with effect from 1 August 2026. Ms. Cheng Wai Chung has been appointed as the new Company Secretary and Authorised Representative, effective the same date.
Tag： Transport International00062.HK
17:05
[ YUEXIU PROPERTY (00123.HK): Subsidiary Proposes to Issue Phase 3 Corporate Bonds of Up to RMB2 Billion with 5-Year and 7-Year Trches ] NewTimeSpace News: On 27 July, Yuexiu Property Company Limited (00123.HK) announced that its subsidiary plans to issue Phase 3 corporate bonds of up to RMB2 billion consisting of 5-year and 7-year tranches with interest rate adjustment, put and call provisions. The bonds carry AAA credit rating and proceeds will be utilised for debt repayment. Interest rates will be determined via bookbuilding.
Tag： YUEXIU PROPERTY00123.HKCorporate Bond
17:00
[ SBP GROUP (01177.HK): Establishes Joint Venture with Indonesia’s Tempo Scan Holding 51% Stake to Expand Innovative Drug Market in Southeast Asia ] NewTimeSpace News: On 27 July, Sino Biopharmaceutical Limited (01177.HK) announced the establishment of a joint venture with Indonesia’s Tempo Scan with a 51% equity stake to develop the innovative drug market across Southeast Asia. Tempo Scan has operated in Indonesia for over 70 years with 16 production bases and 238 distribution outlets. Registration and listing procedures for the initial batch of products are underway. Indonesia’s pharmaceutical market enjoys an annual growth rate of 8%-10%.
Tag： SBP GROUP01177.HKjoint venture company
16:54
[ SHENZHEN EXPRESS(00548.HK): Completes RMB1 Billion Super Short-term Commercial Paper Issuance with Coupon Rate of 1.41% ] NewTimeSpace News: On 27 July 2026, Shenzhen Express(00548.HK) announced that it completed the issuance of RMB1 billion super short-term commercial paper on 24 July 2026. The notes carry a term of 270 days and an interest rate of 1.41%. China CITIC Bank acts as the bookrunner and lead underwriter, with Industrial Bank Co., Ltd. as joint lead underwriter.
Tag： Shenzhen Expressway Corporation LimitedShenzhen Express00548.HKsuper short-term commercial paper
Previous1..244245 246247248..578     578 pages total
×
Share to WeChat

Open WeChat, use "Scan," and share to my Moments